Concepedia

Jean-David Fumet

JF

20

Publications

1.7K

Citations

16

H-Index

2017

Active since

Affiliations

Centre Georges François Leclerc(Current)

Inserm

Genomic and Immunotherapy Medical Institute

Université de Bourgogne

Centre Léon Bérard

Jean-David Fumet is an author at Centre Georges François Leclerc specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2017–2023

20

Publications

20

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 416 citations · Full text

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · British Journal of Cancer · 2019 · 206 citations · Full text

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Emeric Limagne, Lisa Nuttin, Marion Thibaudin et al. · Cancer Cell · 2022 · 199 citations

, , +11

Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients

Emeric Limagne, Corentin Richard, Marion Thibaudin et al. · OncoImmunology · 2019 · 198 citations · Full text

, , +16

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Jean-David Fumet, Corentin Richard, Fanny Ledys et al. · British Journal of Cancer · 2018 · 169 citations · Full text

Rows per page

1–5 of 20